316 related articles for article (PubMed ID: 12548159)
1. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
[TBL] [Abstract][Full Text] [Related]
2. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors.
Barbareschi M; Roldo C; Zamboni G; Capelli P; Cavazza A; Macri E; Cangi MG; Chilosi M; Doglioni C
Am J Surg Pathol; 2004 Sep; 28(9):1169-76. PubMed ID: 15316316
[TBL] [Abstract][Full Text] [Related]
3. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma.
Levine PH; Joutovsky A; Cangiarella J; Yee H; Simsir A
Diagn Cytopathol; 2006 Mar; 34(3):191-5. PubMed ID: 16470859
[TBL] [Abstract][Full Text] [Related]
4. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
Tornillo L; Moch H; Diener PA; Lugli A; Singer G
J Clin Pathol; 2004 Jun; 57(6):641-3. PubMed ID: 15166272
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
[TBL] [Abstract][Full Text] [Related]
6. CDX-2 and HER-3 expression in canine gastric and colorectal adenocarcinomas.
Doster AR; Yhee JY; Kim JH; Im KS; Sur JH
J Comp Pathol; 2011 Jul; 145(1):12-9. PubMed ID: 21238975
[TBL] [Abstract][Full Text] [Related]
7. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.
Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H
Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351
[TBL] [Abstract][Full Text] [Related]
8. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
Raspollini MR; Baroni G; Taddei A; Taddei GL
Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
[TBL] [Abstract][Full Text] [Related]
9. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
[TBL] [Abstract][Full Text] [Related]
10. Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum.
Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A
Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
[TBL] [Abstract][Full Text] [Related]
12. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
Werling RW; Yaziji H; Bacchi CE; Gown AM
Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of CDX-2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks.
Saad RS; Essig DL; Silverman JF; Liu Y
Cancer; 2004 Jun; 102(3):168-73. PubMed ID: 15211476
[TBL] [Abstract][Full Text] [Related]
14. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
[TBL] [Abstract][Full Text] [Related]
15. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
Franchi A; Massi D; Palomba A; Biancalani M; Santucci M
Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880
[TBL] [Abstract][Full Text] [Related]
16. CDX-2 expression is reduced in colorectal carcinomas with solid growth pattern and proximal location, but is largely independent of MSI status.
OkoĊ K; Zazula M; Rudzki Z; Papla B; Osuch C; Stachura J
Pol J Pathol; 2004; 55(3):9-14. PubMed ID: 15619975
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
[TBL] [Abstract][Full Text] [Related]
18. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
Kim MJ
J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458
[TBL] [Abstract][Full Text] [Related]
20. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]